These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Perioperative torsade de pointes: a systematic review of published case reports. Johnston J; Pal S; Nagele P Anesth Analg; 2013 Sep; 117(3):559-564. PubMed ID: 23744954 [TBL] [Abstract][Full Text] [Related]
23. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations. Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427 [TBL] [Abstract][Full Text] [Related]
24. Torsade de pointes in initiating hemodialysis: a case report. Yang JA; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS Ann Palliat Med; 2020 May; 9(3):1264-1268. PubMed ID: 32389016 [TBL] [Abstract][Full Text] [Related]
25. [Acquired long QT syndrome and cardiac arrest after general anesthesia. Case report and review of literature]. Leclercq T; Parrel S; Mierdl S; Cottin Y; Girard C Ann Fr Anesth Reanim; 2014 Jun; 33(6):421-6. PubMed ID: 24880555 [TBL] [Abstract][Full Text] [Related]
26. Ibutilide-induced long QT syndrome and torsade de pointes. Gowda RM; Punukollu G; Khan IA; Patlola RR; Tejani FH; Cosme-Thormann BF; Vasavada BC; Sacchi TJ Am J Ther; 2002; 9(6):527-9. PubMed ID: 12424513 [TBL] [Abstract][Full Text] [Related]
27. Clarithromycin induced torsade de pointes. Hensey C; Keane D Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400 [TBL] [Abstract][Full Text] [Related]
31. Drug-induced long QT syndrome and torsade de pointes. Morissette P; Hreiche R; Turgeon J Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909 [TBL] [Abstract][Full Text] [Related]
32. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111 [TBL] [Abstract][Full Text] [Related]
33. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin. Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486 [TBL] [Abstract][Full Text] [Related]
34. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient. Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302 [TBL] [Abstract][Full Text] [Related]
35. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Tan HL; Hou CJ; Lauer MR; Sung RJ Ann Intern Med; 1995 May; 122(9):701-14. PubMed ID: 7702233 [TBL] [Abstract][Full Text] [Related]
36. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy. Elbey MA; Cil H; Onturk E; Islamoglu Y Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554 [TBL] [Abstract][Full Text] [Related]
37. QT and TdP. QT: an unreliable predictor of proarrhythmia. Hondeghem LM Acta Cardiol; 2008 Feb; 63(1):1-7. PubMed ID: 18372573 [TBL] [Abstract][Full Text] [Related]
38. Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies. Jaiswal A; Goldbarg S Indian Heart J; 2014; 66(6):640-8. PubMed ID: 25634399 [TBL] [Abstract][Full Text] [Related]
39. Drug-induced long QT and torsade de pointes: recent advances. Kannankeril PJ; Roden DM Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043 [TBL] [Abstract][Full Text] [Related]
40. [Clinical observation on pause-dependent long QT syndrome and torsade de pointes ventricular tachycardia]. Song YC Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):349-51, 389. PubMed ID: 1307971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]